evident even when there is subsequent evidence of fetal neurological damage. In over 50% of labours with MSL, however, significant fetal heart abnormalities do occur.
There is evidence that MSL is hazardous to a fetus with acidaernia, increasing the risk of meconium aspiration syndrome (MAS) and associated chorio-amnionitisl-'.
It has always been assumed that thick meconium is more of a risk than thin meconium but in the presence of FHR and FBS measurements, this view is now controversial. In western countries litigation is likely to result if FHR and FBS are not employed in the presence of meconium and intrapartum asphyxia later develops. Some labour ward protocols list meconium as an indication for FBS or consideration for Caesarean section.'.
The dilemma arises in less-developed countries where there are inadequate facilities for such monitoring and where neonatal care is sub-optimal. Here, one must rely on clinical assessment and judgement alone.
The paper by Saunders (page 7) goes some way to offering further advice in managing cases of MSL and analyses 131 cases in a large mission hospital in rural Zimbabwe. It supports the traditional view that thick MSL is associated with poorer outcomes than thin MSL4. It also emphasizes the need to prepare for increased Caesarean rates and intensive neonatal resuscitation.
However, the paper does not address the possibility of reducing the risks of MSL and MAS by amnio infusion. This is a fairly new technique of infusing a saline solution trans-cervically through a fine tube into the uterine cavity to both augment the amniotic fluid volume and dilute the meconium. Usually 500 mL of saline is infused over the first 30 min, then the rate reduced to 2-3 ml.rmin for the rest of the labour. The trials of this technique in Zimbabwe reported in 1998 were particularly encouraging and demonstrated its technical feasibility using simple equipment in a developing country with limited facilities. A considerable improvement in perinatal outcome was shown.'. R B Taylor PhD pathogens will lead to increased morbidity, mortality and a significant economic burden on developing regions of the world. Responsibility for the improvement in quality control rests with the government agencies of the appropriate countries. The technology exists as is demonstrated in the current paper. What is needed, as has been pointed out in a recent letter in the Lancet, is the will to use this technology and to enforce compliance with good manufacturing practice", Two main aspects must be addressed. The government of developing countries must set up effective quality control laboratories with adequate equipment and trained personnel. This would allow proper registration of imported and locally manufactured products. Of equal importance, continuing compliance with standards should be monitored and appropriate post-marketing surveillance systems should be set up. Sadly, we suspect that these solutions are already well understood and it is lack of political will that determines the current lack of resources and suitable infrastructures. . meconium There has been controversy for centuries about the significance of meconium staining of the liquor (MSL). Up to 30 years ago, MSL was regarded as a sign of imminent fetal death 1, but with the advent of fetal heart monitoring (FHR) and fetal blood sampling (FBS), it has been recognized that the presence of meconium may not be as ominous as previously thought. MSL is uncommon before 38 weeks' gestation, but occurs in at least 20% of pregnancies after 42 weeks. The incidence can be much higher in some African populations. Thick meconium can be present at the end of an obstructed labour even when a healthy baby is subsequently delivered by Caesarean section. Conversely, in cases of acute fetal distress, such as occurs in abruption, meconium is rarely
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